CLINICAL_TRIALS
trial_result
· 2021-07-28
Clinical Trial Update: Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study [Phase 3]
Summary
Phase 3 trial update evaluating sildenafil for Fontan-associated liver disease (SiFALD) completed with posted results in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Cirrhosis, Congenital Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-07-28